| RS377767346 |
SMAD4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS377767347 |
SMAD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile polyposis syndrome, Carcinoma of pancreas |
| RS377767348 |
SMAD4
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS377767349 |
SMAD4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767350 |
SMAD4
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767353 |
SMAD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS377767354 |
SMAD4
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767355 |
SMAD4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS377767357 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767358 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767360 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Gallbladder cancer |
| RS377767363 |
SMAD4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767371 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS377767373 |
SMAD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS377767376 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767379 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS377767382 |
SMAD4
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767383 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767385 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS377767386 |
SMAD4
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS377767388 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Medullary thyroid carcinoma, Multiple endocrine neoplasia |
| RS377767390 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767391 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767392 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Multiple endocrine neoplasia |
| RS377767395 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS377767396 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767397 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767398 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767399 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767402 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 2A |
| RS377767404 |
RET
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767405 |
RET
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767406 |
RET
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS377767407 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Multiple endocrine neoplasia type 2B |
| RS377767409 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767411 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767412 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, Multiple endocrine neoplasia |
| RS377767416 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767417 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Multiple endocrine neoplasia type 2B |
| RS377767420 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Medullary thyroid carcinoma, Multiple endocrine neoplasia type 2B |
| RS377767422 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767426 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS377767429 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia type 2B, Multiple endocrine neoplasia |
| RS377767432 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Hereditary cancer-predisposing syndrome |
| RS377767433 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Hereditary cancer-predisposing syndrome |
| RS377767434 |
RET
|
Health Risk |
Pathogenic |
Familial medullary thyroid carcinoma, Familial medullary thyroid carcinoma |
| RS377767436 |
RET
|
Health Risk |
Pathogenic |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA |
| RS377767440 |
RET
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767442 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS377767443 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS377767444 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS377767445 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS377767447 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS377767449 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS377767450 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS3778142 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS3782356 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS3788853 |
XPNPEP2
|
Health Risk |
risk factor |
Susceptibility to angioedema induced by ACE inhibitors, Susceptibility to angioedema induced by ACE inhibitors |
| RS3792267 |
CAPN10
|
Health Risk |
risk factor |
Type 2 diabetes mellitus 1, susceptibility to |
| RS3792876 |
SLC22A4
|
Health Risk |
risk factor |
Rheumatoid arthritis, Rheumatoid arthritis |
| RS3794105 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS3794109 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS3794110 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS3795339 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS3796241 |
CLRN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3, Usher syndrome type 3A |
| RS3796619 |
RNF212
|
Health Risk |
association |
RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1, RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1 |
| RS3797704 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Carcinoma of colon |
| RS3801237 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects, dysmorphic facial features |
| RS3804099 |
TLR2
|
Health Risk |
Conflicting classifications of pathogenicity |
TLR2-related disorder, COVID-19–associated multisystem inflammatory syndrome in adults |
| RS3804100 |
TLR2
|
Health Risk |
Conflicting classifications of pathogenicity |
TLR2-related disorder, COVID-19–associated multisystem inflammatory syndrome in adults |
| RS3809624 |
TBX6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS3809627 |
TBX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondylocostal dysostosis 5, Spondylocostal dysostosis 5 |
| RS3810141 |
BCAM
|
Health Risk |
Pathogenic |
BLOOD GROUP--LUTHERAN NULL, BLOOD GROUP--LUTHERAN NULL |
| RS3810796 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myoclonic epilepsy, Autosomal dominant nonsyndromic hearing loss 65 |
| RS3812597 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS3813227 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS3813244 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS3813249 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS381418 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type I, Gaucher disease type II |
| RS3814182 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS381427 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS381737 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type III, Gaucher disease type II |
| RS3818903 |
SMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS3819330 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS3821204 |
IL1RL1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS3821945 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS3822214 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS3822294 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS3824553 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS3825942 |
LOXL1
|
Health Risk |
Benign; risk factor |
Exfoliation syndrome, susceptibility to |
| RS3826784 |
EIF3G
|
Health Risk |
association |
Cataplexy and narcolepsy, Cataplexy and narcolepsy |
| RS3827075 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Corneal dystrophy-perceptive deafness syndrome |
| RS3829241 |
TPCN2
|
Health Risk |
association |
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN |
| RS3830014 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome |
| RS3831942 |
KCNN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Zimmermann-Laband syndrome 3, Zimmermann-Laband syndrome 3 |
| RS3832024 |
FMO3
|
Health Risk |
Pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS3832095 |
HOXD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly-syndactyly syndrome, Brachydactyly-syndactyly syndrome |
| RS3832799 |
ASCL1
|
Health Risk |
Conflicting classifications of pathogenicity |
ASCL1-related disorder, ASCL1-related disorder |
| RS3833150 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 42, early-onset |
| RS3833180 |
CTDP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |